HIV infection: epidemiology, pathogenesis, treatment, and prevention

G Maartens, C Celum, SR Lewin - The Lancet, 2014‏ - thelancet.com
HIV prevalence is increasing worldwide because people on antiretroviral therapy are living
longer, although new infections decreased from 3· 3 million in 2002, to 2· 3 million in 2012 …

Global epidemiology of HIV among female sex workers: influence of structural determinants

K Shannon, SA Strathdee, SM Goldenberg, P Duff… - The Lancet, 2015‏ - thelancet.com
Female sex workers (FSWs) bear a disproportionately large burden of HIV infection
worldwide. Despite decades of research and programme activity, the epidemiology of HIV …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel

HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron… - Jama, 2016‏ - jamanetwork.com
Importance New data and therapeutic options warrant updated recommendations for the use
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada

H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff… - PloS one, 2013‏ - journals.plos.org
Background Combination antiretroviral therapy (ART) has significantly increased survival
among HIV-positive adults in the United States (US) and Canada, but gains in life …

Human immunodeficiency virus transmission at each step of the care continuum in the United States

J Skarbinski, E Rosenberg, G Paz-Bailey… - JAMA internal …, 2015‏ - jamanetwork.com
Importance Human immunodeficiency virus (HIV) transmission risk is primarily dependent
on behavior (sexual and injection drug use) and HIV viral load. National goals emphasize …

Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection

SL Walmsley, A Antela, N Clumeck… - … England Journal of …, 2013‏ - Mass Medical Soc
Background Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was
recently approved in the United States for the treatment of human immunodeficiency virus …

HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy

JB Honeycutt, WO Thayer, CE Baker, RM Ribeiro… - Nature medicine, 2017‏ - nature.com
Despite years of fully suppressive antiretroviral therapy (ART), HIV persists in its hosts and is
never eradicated. One major barrier to eradication is that the virus infects multiple cell types …

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled …

B Grinsztejn, MC Hosseinipour, HJ Ribaudo… - The Lancet infectious …, 2014‏ - thelancet.com
Background Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …

Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America

JA Aberg, JE Gallant, KG Ghanem… - Clinical Infectious …, 2014‏ - academic.oup.com
Evidence-based guidelines for the management of persons infected with human
immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine …

[HTML][HTML] Highly active antiretroviral therapy (HAART)

JS Eggleton, S Nagalli - 2020‏ - europepmc.org
Objectives: Describe the treatment considerations for patients with HIV. Identify the most
common adverse events associated with highly active antiretroviral therapy (HAART) …